These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10452555

  • 1. Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted to the polypurine tract.
    Hiratou T, Tsukahara S, Miyano-Kurosaki N, Takai K, Yamamoto N, Takaku H.
    FEBS Lett; 1999 Jul 30; 456(1):186-90. PubMed ID: 10452555
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-HIV-1 activity by a triple-helix forming oligonucleotides targeted to polypurine tract on viral RNA.
    Hiratou T, Tsukahara S, Miyano-Kurosaki N, Takai K, Saito T, Yamamoto N, Takaku H.
    Nucleosides Nucleotides Nucleic Acids; 2000 Jul 30; 19(10-12):1721-34. PubMed ID: 11200268
    [Abstract] [Full Text] [Related]

  • 5. A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA.
    Hiratou T, Miyano-Kurosaki N, Gushima H, Takaku H.
    Nucleosides Nucleotides Nucleic Acids; 2001 Jul 30; 20(4-7):715-8. PubMed ID: 11563099
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.
    Tsukahara S, Suzuki J, Hiratou T, Takai K, Koyanagi Y, Yamamoto N, Takaku H.
    Biochem Biophys Res Commun; 1997 Apr 28; 233(3):742-7. PubMed ID: 9168925
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA.
    Volkmann S, Jendis J, Frauendorf A, Moelling K.
    Nucleic Acids Res; 1995 Apr 11; 23(7):1204-12. PubMed ID: 7537875
    [Abstract] [Full Text] [Related]

  • 8. The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides.
    Volkmann S, Dannull J, Moelling K.
    Biochimie; 1993 Apr 11; 75(1-2):71-8. PubMed ID: 7684936
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cells.
    El Dirani-Diab R, Sarih-Cottin L, Delord B, Dumon B, Moreau S, Toulme JJ, Fleury H, Litvak S.
    Antimicrob Agents Chemother; 1997 Oct 11; 41(10):2141-8. PubMed ID: 9333039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oligonucleotides as inhibitors of human immunodeficiency virus.
    Field AK.
    Curr Opin Mol Ther; 1999 Jun 11; 1(3):323-31. PubMed ID: 11713797
    [Abstract] [Full Text] [Related]

  • 14. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T, Hosono K, Takai K, Ushijima K, Nakashima H, Saito T, Yamamoto N, Takaku H.
    Biochem Biophys Res Commun; 1996 Nov 12; 228(2):623-31. PubMed ID: 8920960
    [Abstract] [Full Text] [Related]

  • 15. Single stand targeted triplex formation: physicochemical and biochemical properties of foldback triplexes.
    Kandimalla ER, Manning A, Agrawal S.
    J Biomol Struct Dyn; 1996 Aug 12; 14(1):79-90. PubMed ID: 8877564
    [Abstract] [Full Text] [Related]

  • 16. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P, Prasad VR.
    J Virol; 2002 Jul 12; 76(13):6545-57. PubMed ID: 12050367
    [Abstract] [Full Text] [Related]

  • 17. Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.
    Xodo L, Alunni-Fabbroni M, Manzini G, Quadrifoglio F.
    Nucleic Acids Res; 1994 Aug 25; 22(16):3322-30. PubMed ID: 8078767
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
    Park WS, Miyano-Kurosaki N, Abe T, Takai K, Yamamoto N, Takaku H.
    Biochem Biophys Res Commun; 2000 Apr 21; 270(3):953-60. PubMed ID: 10772932
    [Abstract] [Full Text] [Related]

  • 19. Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2.
    Boulme F, Perälä-Heape M, Sarih-Cottin L, Litvak S.
    Biochim Biophys Acta; 1997 Apr 10; 1351(3):249-55. PubMed ID: 9130587
    [Abstract] [Full Text] [Related]

  • 20. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
    Boulmé F, Freund F, Moreau S, Nielsen PE, Gryaznov S, Toulmé JJ, Litvak S.
    Nucleic Acids Res; 1998 Dec 01; 26(23):5492-500. PubMed ID: 9826777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.